Reliance Life Sciences Private Limited: Azacitidine For Injection 100mg/vial, 1
Azacitidine for Injection 100mg/Vial manufactured by Reliance Life Sciences for Somerset Therapeutics is being recalled nationwide because it may not meet sterility standards, meaning it could potentially be contaminated. The recall affects all states in the U.S. and applies to the product with NDC 70069-0857-01. This is a Class II recall, indicating a serious health hazard, though the contamination risk is not certain.
- Recalling firm
- Reliance Life Sciences Private Limited
- Product
- Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0857-01
- Reason
- Lack of Sterility Assurance
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-06-24
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/eab46185-42c2-4a33-a4b8-c1a46cb656fc